Paperpal Prime Logo

Movement Disorders : Impact Factor & More

eISSN: 1531-8257pISSN: 0885-3185

Aims and Scope of Movement Disorders

Movement Disorders is a peer-reviewed medical journal, first published in 1986. The journal focuses on original research relating to clinical neurology topics.

Key Metrics

CiteScore
13.3
Eigenfactor
0.01 - 0.05
H-Index
219
Impact Factor
5 - 10
Scite Index
0.88 5-Year SI
SJR
Q1Neurology
SNIP
2.46
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Movement Disorders

Movement Disorders Journal Specifications

Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Movement Disorders ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Movement Disorders

Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.
  • 7 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.
  • 7 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Type 2 α-Synuclein Seed Amplification as a Diagnostic Reassessment Signal in Parkinson's Progression Markers Initiative Parkinson's Disease.
  • 6 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies.
  • 5 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Reply to: "What Does α-Syn-SAA-Negative Parkinson's Disease Reveal about the Proposed "Biological Definition" of Parkinson's Disease?"
  • 4 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Complementary Mitochondrial and α-Synuclein Signatures Refine Biological Stratification of Parkinson's Disease.
  • 4 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.
  • 7 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.
  • 7 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Type 2 α-Synuclein Seed Amplification as a Diagnostic Reassessment Signal in Parkinson's Progression Markers Initiative Parkinson's Disease.
  • 6 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies.
  • 5 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Reply to: "What Does α-Syn-SAA-Negative Parkinson's Disease Reveal about the Proposed "Biological Definition" of Parkinson's Disease?"
  • 4 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society
Complementary Mitochondrial and α-Synuclein Signatures Refine Biological Stratification of Parkinson's Disease.
  • 4 Aug 2026
  • Movement disorders : official journal of the Movement Disorder Society

FAQs on Movement Disorders